# Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients

> **NCT04379037** · NA · COMPLETED · sponsor: **Nemechek Technologies** · enrollment: 50 (actual)

## Conditions studied

- Severe Acute Respiratory Syndrome Coronavirus 2

## Interventions

- **DEVICE:** Transcutaneous Auricular Vagus Nerve Stimulation

## Key facts

- **NCT ID:** NCT04379037
- **Lead sponsor:** Nemechek Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-27
- **Primary completion:** 2020-09-01
- **Final completion:** 2020-11-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04379037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04379037, "Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04379037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*